Introduction
Sepsis is defined as the presence or presumed presence of an infection accompanied by evidence of a systemic response called the systemic inflammatory response syndrome [1] . Recently Vincent et al. defined as host's deleterious, non-resolving inflammatory response to infection that leads to organ dysfunction [2] . Although 
P E E R R E V I E W A B S T R A C T
Sepsis is one of the major causes and predictors of death in patients with visceral leishmaniasis (VL). Globally, incidence rate of sepsis ranged from 56-91 cases per 100 000 people, with a mortality rate of 30%. Incidence of sepsis has been raised due to aging of the population and the higher incidence of immunosuppressive conditions such as HIV, VL and others. The prevalence of sepsis was reported from 4 sepsis can be caused by viruses and fungi, most is due to bacterial infections [3] . Recent review by Jawad et al. revealed that the incidence rate of sepsis ranged from 56-91 cases per 100 000 people, with a reported mortality rate of 30% [4] . Incidence of sepsis is increasing due to nosocomial infection, aging of the population and the higher incidence of immunosuppressive conditions such as HIV/AIDS [5] , visceral leishmaniasis (VL) and VL-HIV coinfection and others [6] [7] [8] .
VL is one of the most neglected infectious diseases [9] . Over 90% of the estimated annual incidence in half a million VL cases worldwide occur in just six countries which are Bangladesh, India, Nepal, Sudan, Ethiopia and Brazil [10] [11] [12] . The highest prevalence of VL-HIV coinfection in the world was reported from Eastern African region reached up to 40% [10, 13] .
Patients with VL usually present with fever, weight loss, organomegaly and pancytopenia. Leishmania donovani, etiologic agent of VL, targets reticuloendothelial system, spleen, liver, bone marrow and lymph nodes [9] . Leishmania invade and replicate within host macrophages, evading innate and cell-mediated immune responses. Patients with VL show a continuum of immune responses from protective to non-protective [14] . Leucopenia, malnutrition and lack protective responses to Leishmania and other antigens including bacteria, predispose patients with VL to bacterial infections [15, 16] .
Studies conducted on the prevalence of sepsis ranged from 3% to 28% among VL patients [6] [7] [8] [17] [18] [19] [20] [21] . Although sepsis has high prevalence and affects the outcome of patients with VL, the causative agents and their antimicrobial susceptibility patterns are poorly understood. Under knowing the current magnitude of sepsis in immuno-compromised individuals such as VL and VL-HIV coinfected patients, it is important to take rational management for them. This review, therefore aims to compile available information on the prevalence, associated risk factors and etiologic agents of bacterial sepsis in patients with VL and VL-HIV co-infection.
Methods
This review was developed after reviewing the pertinent information available about sepsis among patients with VL and VL-HIV co-infection from Hinari, Entrez-PubMed and Google Scholar web sites.
Sepsis

Prevalence of sepsis
The prevalence of sepsis in patients with VL and VL-HIV coinfected patients in the world is not clearly known. Recent studies showed sepsis was a main factor that affected the treatment outcome of patients with VL [22] . Bacterial infections and sepsis among VL and VL-HIV coinfected patients have been reported ranging from 15% to 84% and 3% to 28%, respectively ( Table 1) . Admitted VL (n=30) [6] Brazil 27.5% 9.1%
Paediatric VL (n=120) [21] Iran 41.0%
13.0% Paediatric VL (n=54) [7] Albania 
Associated risk factors
The increased susceptibility of VL patients to bacterial infections leads sepsis to be multi-factorial. Immunosuppression, leucopenia and malnutrition are the most important factors associated with susceptibility to bacterial infections [8, 17] . Extreme age (age <1 year old and >40 years old) and HIV are the factors associated with bacterial sepsis [8] . Malnutrition, pulmonary rales, severe anemia, severe absolute neutropenia and higher neutrophil count were also identified as risk factors related to bacterial infections that lead to death in patients with VL [15] . Neutropenia associated with bacteremia is common in immune-compromised patients including cancer patients [23] .
Increased exposure to potentially resistant bacteria in nursing homes and utilization of insufficiently sterilized medical devices including indwelling catheters and central venous lines will also increase risks. Patients with VL treated in hospital had significantly higher rates of complications than those treated on outpatient basis (P<0.001) [8] .
Sources for sepsis
The sources for sepsis are bacterial infections elsewhere in the body that include: lungs, wounds, soft tissues, central nervous system and urinary tract infections. Bacterial infections (such as pneumonia, otitis media, and gastrointestinal infections) cause sepsis, which are common in patients with VL ranging from 15% to 84% [6] [7] [8] [17] [18] [19] [20] [21] [24] [25] [26] .
Patients with VL will stay in hospital for at least 30 d for the treatment of VL. In this period, they will be treated with the drugs (such as sodium stibogluconate, amphotericin b) intravenously. This intravenous dwelling may also contribute to the entrance of bacterial agents. A few studies in Ethiopia also reported bacterial infections ranging from 15% to 42.8% and 40% in patients with VL and VL-HIV coinfection, respectively [8, 18, 19, 26] .
Etiologic agents and their antimicrobial susceptibility patterns
Both Gram-positive and Gram-negative bacteria were isolated from patients with VL (Table 2 ). Among the Grampositives, Staphylococcus aureus were the predominateing isolate. Unexpected Gram-negative bacteria such as Shigella was also reported from a VL case in Ethiopia [27] . Although some bacteria were isolated from patients with VL, their antimicrobial susceptibility patterns are not well studied (Table 2 ).
Mortality due to sepsis
Sepsis is a life-threatening disease that may lead to shock, multiple organ failure, and death, especially if not recognized early and treated promptly. Millions of people die of sepsis every year worldwide [28] . Bloodstream infections are usually serious infections typically causing a prolonged hospital stay, increased cost and risk of mortality, especially when it occurs with other co-infections like HIV [29] . Sepsis is the primary cause of death that contributes 34% to 75% of the total deaths in patients with VL [18, [20] [21] [22] 26] . Bacterial sepsis still remains the primary cause of death from infection in spite of advanced modern medicine, including vaccines, antibiotics and acute care.
Sepsis was one of the associated factors with poor treatment outcome (death) [19] .
Conclusion
Sepsis is an important health problem causing death of VL and VL-HIV coinfected patients. Sepsis in VL patients is associated with immune suppression, pancytopenia, HIV coinfection, age <1 year old and >40 years old, indwelling of central venous lines and hospitalization. Bacterial infections such as pneumonia, otitis media, and gastrointestinal infections leading to sepsis were common among VL patients. Both Gram-positive and Gram-negative bacteria were isolated from blood cultures of sepsis suspected VL patients. VL and VL-HIV coinfected patients that are affected by bacterial infections (such as pneumonia, otitis media, gastrointestinal infections), which cause sepsis, should be diagnosed and treated early. Optimal infection control measures should be taken by concerned bodies in order to reduce nosocomial sepsis. Indwelling of central venous 
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Comments
Background
Sepsis is the presence of an infection accompanied by evidence of systemic inflammatory response syndrome. Incidence of sepsis is increasing due to nosocomial infection, aging of the population and the higher incidence of immunosuppressive conditions such as HIV/AIDS, VL and VL-HIV co-infection and others. VL is one of the neglected diseases in the world, affecting the poorest segment of rural populations. Studies have shown that the prevalence of sepsis ranged from 3 % to 28 % among VL patients. Therefore, knowing the current magnitude of sepsis in immuno-compromised individuals such as VL and VL-HIV co-infected patients is important for rational management of patients.
Research frontiers
A s V L a n d V L -H I V c o -i n f e c t e d p a t i e n t s a r e immunocompromized patients and studies showed that bacterial sepsis is becoming an important concern in this population segment. VL is one of the neglected diseases in developing countries where bacterial infection is equally important, hence addressing this problem may be important for increasing awareness of the community and give better attention for patient management.
Related reports
In recent reports sepsis was the main factor that affects the treatment outcome of patients with VL ( 
Innovations and breakthroughs
A s V L a n d V L -H I V c o -i n f e c t e d p a t i e n t s a r e immunocompromized patients, in the present study authors have demonstrated the importance of bacterial sepsis in this population segments which become important public health concern.
Applications
It has been found that sepsis is the primary cause of death that contributes to a significant number of deaths in patients with VL. Addressing this issue may be important for increasing awareness of the community and give better attention for patient management.
Peer review
This review is a valuable work in which authors have demonstrated that VL and VL-HIV co-infected patients affected by bacterial infections leading to sepsis, should be diagnosed and treated early. Optimal infection control measures should be timely taken in order to reduce nosocomial sepsis. Indwelling of central venous lines for immune-suppressed patients such as VL and VL-HIV coinfected should be reduced as much as possible.
